Skip to content

Inhibrx Biosciences, Inc. INBX Shares Reserved for Future Issuance Under Stock Plans

Shares Reserved for Future Issuance Under Stock Plans at other companies

Merck & Co. logo
Merck & Co.MRK
66M-12.0%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+546%
Enterprise value$1.42B+1,233%
P/S1,073.7×-280×

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s shares reserved for future issuance under stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s shares reserved for future issuance under stock plans?
Inhibrx Biosciences, Inc. (INBX) reported shares reserved for future issuance under stock plans of 5M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
Inhibrx Biosciences, Inc.'s shares reserved for future issuance under stock plans decreased by 2.1% year-over-year, from 5.1M to 5M.
What is the long-term trend for Inhibrx Biosciences, Inc.'s shares reserved for future issuance under stock plans?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s shares reserved for future issuance under stock plans has grown at a -39.0% compound annual growth rate (CAGR), from 13.8M to 5.1M.
What does shares reserved for future issuance under stock plans mean?
This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.